FRESENIUS MEDICAL CARE AG Cash And Cash Equivalents
FRESENIUS MEDICAL CARE AG (FMCQF) had Cash And Cash Equivalents of EUR 1.60 billion as of 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-02-24
- 2025-12-31: Cash And Cash Equivalents 1.60B EUR.
- 2025-09-30: Cash And Cash Equivalents 1.26B EUR.
- 2025-06-30: Cash And Cash Equivalents 1.72B EUR.
- 2025-03-31: Cash And Cash Equivalents 1.07B EUR.
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | 1.60B EUR 20-F · filed 2026-02-24 | |
| 2025-09-30 | 1.26B EUR 6-K · filed 2025-11-04 | |
| 2025-06-30 | 1.72B EUR 6-K · filed 2025-08-05 | |
| 2025-03-31 | 1.07B EUR 6-K · filed 2025-05-06 | |
| 2024-12-31 | 1.18B EUR 20-F · filed 2026-02-24 | |
| 2024-09-30 | 1.37B EUR 6-K · filed 2024-11-05 | |
| 2024-06-30 | 1.09B EUR 6-K · filed 2024-07-30 | |
| 2024-03-31 | 1.15B EUR 6-K · filed 2024-05-07 | |
| 2023-12-31 | 1.40B EUR 20-F · filed 2025-02-25 | |
| 2023-09-30 | 1.55B EUR 6-K · filed 2023-11-02 | |
| 2023-06-30 | 1.36B EUR 6-K · filed 2023-08-02 | |
| 2023-03-31 | 1.22B EUR 6-K · filed 2023-05-09 | |
| 2022-12-31 | 1.27B EUR 20-F · filed 2024-02-20 | |
| 2022-09-30 | 1.11B EUR 6-K · filed 2022-10-31 | |
| 2022-06-30 | 1.02B EUR 6-K · filed 2023-08-02 | |
| 2022-03-31 | 1.17B EUR 6-K · filed 2023-05-09 | |
| 2021-12-31 | 1.48B EUR 6-K · filed 2023-08-02 | |
| 2021-09-30 | 1.56B EUR 6-K · filed 2022-10-31 | |
| 2021-06-30 | 1.41B EUR 6-K · filed 2022-08-02 | |
| 2021-03-31 | 1.07B EUR 6-K · filed 2022-05-04 | |
| 2020-12-31 | 1.08B EUR 20-F · filed 2023-02-22 | |
| 2020-09-30 | 1.60B EUR 6-K · filed 2021-11-02 | |
| 2020-06-30 | 1.89B EUR 6-K · filed 2021-07-30 | |
| 2020-03-31 | 1.05B EUR 6-K · filed 2021-05-06 | 1.41B EUR 6-K · filed 2020-05-06 |
| 2019-12-31 | 1.01B EUR 20-F · filed 2023-02-22 | |
| 2019-09-30 | 965.05M EUR 6-K · filed 2020-10-29 | |
| 2019-06-30 | 922.10M EUR 6-K · filed 2020-07-30 | |
| 2019-03-31 | 958.79M EUR 6-K · filed 2020-05-06 | |
| 2019-01-01 | 2.15B EUR 6-K · filed 2019-07-30 | 958.79M EUR 6-K · filed 2019-05-02 |
| 2018-12-31 | 2.15B EUR 20-F · filed 2022-02-22 | |
| 2018-09-30 | 1.75B EUR 6-K · filed 2019-10-31 | |
| 2018-06-30 | 1.66B EUR 6-K · filed 2019-07-30 | |
| 2018-03-31 | 1.66B EUR 6-K · filed 2019-07-30 | 846.38M EUR 6-K · filed 2018-05-03 |
| 2018-01-01 | 978.11M EUR 6-K · filed 2019-07-30 | |
| 2017-12-31 | 978.11M EUR 20-F · filed 2021-02-23 | |
| 2017-09-30 | 729.24M EUR 6-K · filed 2018-10-30 | |
| 2017-06-30 | 720.98M EUR 6-K · filed 2018-08-01 | |
| 2017-03-31 | 670.58M EUR 6-K · filed 2018-05-03 | |
| 2017-01-01 | 978.11M EUR 6-K · filed 2019-07-30 | 708.88M EUR 6-K · filed 2018-05-03 |
| 2016-12-31 | 708.88M EUR 20-F · filed 2020-02-20 | |
| 2016-01-01 | 504.73M EUR 20-F · filed 2019-02-20 | |
| 2015-12-31 | 504.73M EUR 20-F · filed 2018-02-27 | |
| 2014-12-31 | 522.08M EUR 20-F · filed 2018-02-27 |